Epigenetics and Neuroplasticity - Evidence and Debate

Erscheinungsjahr 2014
ISBN: 978-0-12-800977-2
Verlag: William Andrew Publishing

Buch, Englisch, 250 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 590 g

The 'epi-(Greek for 'over', 'above')genome', with its rich cache of highly regulated, structural modifications-including DNA methylation, histone modifications and histone variants-defines the moldings and three-dimensional structures of the genomic material inside the cell nucleus and serves, literally, as a molecular bridge linking the environment to the genetic materials in our brain cells. Due to technological and scientific advances in the field, the field of neuroepigenetics is currently one of the hottest topics in the basic and clinical neurosciences. The volume captures some of this vibrant and exciting new research, and conveys to the reader an up-to-date discussion on the role of epigenetics across the lifespan of the human brain in health and disease.

Zielgruppe

Basic and clinical neuroscientists, and students interested in the field of neuroepigenetics

Autoren/Hrsg.

Weitere Mitwirkende

Akbarian, Schahram

Lubin, Farah

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Neurologie, Klinische Neurowissenschaft

Inhaltsverzeichnis

- The Epigenetic Basis of Memory Formation and Storage
Timothy J. Jarome, Jasmyne S. Thomas and Farah D. Lubin
- Epigenetics in Post-Traumatic Stress Disorder.
Carina Rampp, Elisabeth B. Binder and Nadine Provençal

- Histone-Mediated Epigenetics in Addiction
Leah N. Hitchcock and K. Matthew Lattal
- Modeling the Molecular Epigenetic Profile of Psychosis in Prenatally Stressed Mice
Alessandro Guidotti, Erbo Dong, Patricia Tueting and Dennis R. Grayson
- Epigenetics of Depression
Sermsak Lolak, Pim Suwannarat and Robert H. Lipsky
- Epigenetic Factors and Intellectual Disability: The Rubinstein-Taybi Syndrome as a Paradigm of Neurodevelopmental Disorder with Epigenetic Origin
Jose P. Lopez-Atalaya, Luis M. Valor and Angel Barco
- The Intergenerational Effects of Early Adversity
Janina Galler and Danielle Galler Rabinowitz
- The Future of Neuroepigenetics in the Human Brain
Amanda Mitchell, Panos Roussos, Cyril Peter, Nadejda Tsankova and Schahram Akbarian

Über Autor(innen)

Lubin, Farah
Schahram Akbarian studied medicine at the Freie Universitaet Berlin, Germany. He is a board certified psychiatrist and molecular neuroscientist who trained at the Massachusetts General Hospital in Boston, the Whitehead Institute for Biomedical Research in Cambridge and the University of California at Irvine. In 2002, he joined the University of Massachusetts Medical School in Worcester where he established a research program in psychiatric epigenetics and served as the Director of the Brudnick Neuropsychiatric Research Institute. Presently, he heads the Division of Psychiatric Epigenomics in the Departments of Psychiatry and Neuroscience at Mount Sinai School of Medicine. He is a former recipient of the Klerman award from the Brain & Behavior Research Foundation, the Judith Silver Memorial award of the National Alliance for the Mentally Ill, the Outstanding resident award of the National Institute of Mental Health, and the Eva King Killam Award for Outstanding Translational Research, American College of Neuropsychopharmacology.

Dr. Akbarian has been a principal investigator on National Institutes of Health-funded research projects since 2001and published close to 100 articles in scientific journals and book chapters. He is a member of professional societies such as the American College of Neuropsychopharmacology and presently serves on the Scientific Advisory Board of the Brain & Behavior Research Foundation and on Editorial Boards of various journals in the field

Akbarian, Schahram
Schahram Akbarian studied medicine at the Freie Universitaet Berlin, Germany. He is a board certified psychiatrist and molecular neuroscientist who trained at the Massachusetts General Hospital in Boston, the Whitehead Institute for Biomedical Research in Cambridge and the University of California at Irvine. In 2002, he joined the University of Massachusetts Medical School in Worcester where he established a research program in psychiatric epigenetics and served as the Director of the Brudnick Neuropsychiatric Research Institute. Presently, he heads the Division of Psychiatric Epigenomics in the Departments of Psychiatry and Neuroscience at Mount Sinai School of Medicine. He is a former recipient of the Klerman award from the Brain & Behavior Research Foundation, the Judith Silver Memorial award of the National Alliance for the Mentally Ill, the Outstanding resident award of the National Institute of Mental Health, and the Eva King Killam Award for Outstanding Translational Research, American College of Neuropsychopharmacology.

Dr. Akbarian has been a principal investigator on National Institutes of Health-funded research projects since 2001and published close to 100 articles in scientific journals and book chapters. He is a member of professional societies such as the American College of Neuropsychopharmacology and presently serves on the Scientific Advisory Board of the Brain & Behavior Research Foundation and on Editorial Boards of various journals in the field